Ospanov O 1
1. The first modified Delphi consensus statement on sleeve gastrectomy
2. A laparoscopic one anastomosis gastric bypass with wrapping versus nonwrapping fundus of the excluded part of the stomach to treat obese patients (FundoRingOAGB trial): study protocol for a randomized controlled trial
3. A Randomized Controlled Trial of Acid and Bile Reflux Esophagitis Prevention by Modified Fundoplication of the Excluded Stomach in One-Anastomosis Gastric Bypass: 1-Year Results of the FundoRing Trial
4. A Three-Arm Randomized Controlled Trial of Primary One-Anastomosis Gastric Bypass: With FundoRing or Nissen Fundoplications vs. without Fundoplication for the Treatment of Obesity and Gastroesophageal Reflux Disease
5. Biography: Oral Ospanov, M.D., PhD, DMedSc, Professor
6. Comparative endoscopic ultrasound assessment of the gastric pouch after FundoRing-OAGB and OAGB
7. Comparison of Dumping Syndrome After FundoRing and Standard One-anastomosis Gastric Bypass: A Randomized Controlled Trial
8. Laparoscopic use excluded part of the stomach to prevent negative consequences after gastric bypass
9. One anastomosis gastric bypass with fundoplication of remnant stomach for weight regain prevention: Case report
10. Regarding “Revision/Conversion Surgeries After One Anastomosis Gastric Bypass—An Experts’ Modified Delphi Consensus”
11. Standardization of surgical technique of the fundoring method for laparoscopic gastric bypass
12. Stapleless vs Stapled Gastric Bypass vs Hypocaloric Diet: a Three-Arm Randomized Controlled Trial of Body Mass Evolution with Secondary Outcomes for Telomere Length and Metabolic Syndrome Changes
13. Thank IFSO for the Support that Allowed to Include the Specialization “Bariatric and Metabolic Surgery” in the Healthcare System of Kazakhstan
14. The laparoscopic rating scale for the evaluation of working conditions for surgical treatment of super-obesity
15. The Surgical Technique of Primary Modified Fundoplication Using the Excluded Stomach with Simultaneous Gastric Bypass
16. Training and Certification for the Bariatric and Metabolic Surgery Specialization in Kazakhstan
17. Global burden of metabolic diseases, 1990–2021
18. Burden of disease attributable to high body mass index: an analysis of data from the Global Burden of Disease Study 2021
19. Erratum: Burden of disease attributable to high body mass index: an analysis of data from the Global Burden of Disease Study 2021 (eClinicalMedicine (2024) 76, (S2589537024004279), (10.1016/j.eclinm.2024.102848))
20. Global burden of disease attributable to metabolic risk factors in adolescents and young adults aged 15–39, 1990–2021
1